Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Hero Technologies Inc. (HENC) Looks to Expand as States Report $3.7B in Cannabis Recreational Tax Revenue in 2021

  • MPP report notes that states with legalized marijuana for adult use generated $3.7 billion in tax revenue from recreational cannabis sales
  • HENC is looking to leverage its cannabis expertise in more of these states
  • Company is aggressively pursuing expansion into Colorado, Massachusetts

A new report reveals that states with legalized recreational marijuana collected an estimated $3.7 billion in tax revenues last year (https://cnw.fm/xP9p5). That news bodes well for savvy players in the legal cannabis space, including Hero Technologies (OTC: HENC), as states are often eager to support revenue sources. 

“States that have legalized marijuana for adult use collectively generated more than $3.7 billion in tax revenue from recreational cannabis sales in 2021, a report from the Marijuana Policy Project (‘MPP’) that was released on Wednesday found,” reported Marijuana Moment. “That’s a 34% increase compared to revenue that states received from cannabis sales in 2020.

“The report follows up on an analysis MPP put out in January that looked at the total adult-use cannabis tax revenue collected by all legal states since recreational sales started in Colorado and Washington State in 2014,” the article continued. “At the time, the 2021 figures were incomplete but still showed that states received more than $10 billion in tax dollars from recreational marijuana sales over the past seven years. Now that the data is updated for 2021, the organization says the 2014–2022 total as of March is $11.2 billion.”

While cannabis remains on the federal list of banned substances outlined in the 1970 Controlled Substances Act (“CSA”), a growing number of states have passed laws providing for the medical or recreational legal use of the drug, with some states legalizing both uses. 

“According to 2020 U.S. Census Bureau apportionment numbers, more than 145 million Americans now live in a state that has legalized marijuana,” a U.S. News article reports (https://cnw.fm/MSLdN). The article went to note that “the wave of initiatives to legalize marijuana began in 2012, and has mostly been driven by coastal states.” The article also projected that more states are likely to join those ranks in the coming years, as about two-thirds of American adults support marijuana legalization, according to a Pew Research Center. Survey.

Hero Technologies is looking to leverage its cannabis expertise in more of these states. The company currently has a majority stake in BlackBox Systems and Technologies LLC, which has been operating legally in Michigan as a medical caregiver. BlackBox Systems is an aeroponic cannabis cultivation system that provides optimal conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased efficiencies. HENC is aggressively pursuing an expansion of its cultivation and dispensary operations in Colorado through Mile High Green LLC, a wholly owned subsidiary. The company is also looking to move into Massachusetts through an additional wholly owned subsidiary, MassCannabis LLC. 

These three states are in the top-six cannabis markets in the United States (https://cnw.fm/ZI3H1). While California tops the list, Colorado comes in at number three, reporting a $2.5 billion market, with Michigan following in the number-four spot, showing a $1.4 billion market. Massachusetts ranks number six, with a market of $1.2 billion.

For more information, visit the company’s website at www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — International Poll Indicates Most Europeans Favor Cannabis Legalization

Even though most territories across the world have outlawed cannabis for decades, the controversial plant has consistently been one of the most-used drugs on the planet. Now that support for drug reform is sweeping the globe, it is becoming clear that a growing number of people around the world are in favor of legalizing marijuana.

A new poll has found that just as in North America, a significant percentage of Europeans support cannabis legalization. The study comes as more and more European countries are considering lifting prohibition policies and allowing medical and even recreational marijuana.

Partly sponsored by Curaleaf International, the Hanway Associates poll surveyed Europeans in eight countries and posed the following question to them: Are you in favor of legalizing and regulating cannabis consumption for adults aged 18 years and older?  Survey participants came from Germany, France, Italy, the Netherlands, Spain, Portugal, the United Kingdom and Switzerland.

On average, 55% of the respondents were in favor of allowing recreational cannabis use, while 25% revealed that they oppose adult-use cannabis and 18% were not sure. Participants from the Netherlands were particularly supportive of cannabis reform, with a majority of them stating that they were in favor of legalizing the plant for recreational use.

Charlotte Bowyer, head of advisory at Hanway Associates and coauthor of the report, says the findings show that cannabis reform in Europe is now a question of when not if. On top of asking for their views on cannabis legalization, the poll also queried respondents on their thoughts on different types of regulatory models for cannabis sales. This includes the traditional cannabis retailers that are now popping up in America in legal states, home cultivation for personal use or social clubs that allow customers to purchase cannabis and consume it onsite.

The survey showed 48% of the respondents said that they were in favor of regulated retail cannabis stores, 35% preferred a noncommercial model that supported home cultivation, while 32% supported marijuana social clubs that would allow onsite consumption. Interestingly, the model that saw the most opposition across the board was home cultivation with 41% of the respondents opposing the model.

The authors of the report suggest that this may be due to a NIMBY, or “not in my backyard,” attitude where people don’t mind policies and laws that they perceive as unpleasant as long as they aren’t affecting where they live. In this case, the respondents, especially those in France and the UK, may not want to be exposed to other people’s marijuana use.

This poll showing that most people in Europe are in favor of ending the prohibition of marijuana gives internationally focused cannabis companies such as Flora Growth Corp. (NASDAQ: FLGC) plenty to think about as they plan their entries into those markets once regulatory reforms are enacted.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana to Add Approximately $100B to American Economy This Year

Despite being prohibited by federal law, cannabis has quickly become one of the most lucrative industries in the country. After only a few short years of legalization, the state-legal marijuana industry has generated billions of dollars in sales and filled state coffers with billions of dollars in cannabis sales taxes.

Furthermore, the industry has created more than 300,000 new job opportunities across the country. Cannabis was one of the few industries considered essential at the start of the coronavirus pandemic, and it managed to consistently break sales records while other sectors struggled to keep their doors open.

With lawmakers considering federal legalization, cannabis may prove to be even more lucrative in the future. According to an analysis from the MJBiz Factbook, marijuana sales are poised to add a whopping $99 billion to the U.S. economy this year. By 2026, the impact of cannabis sales on the American economy will be greater than $155 billion.

Published by the MJBizDaily, the data shows that cannabis could have a significant positive impact on the economy, especially if federal limitations are removed. Researchers from MJBizDaily studied industries that have similarities to the marijuana sector, deliberated with economists, and multiplied projected medical and recreational cannabis retail sales by a standard multiplier of 2.8 to measure marijuana’s projected impact on the economy.

However, their results cannot be taken as concrete proof of the industry’s impact because cannabis has a unique structure compared to other sectors. For starters, it is illegal under federal law and has to operate under a multitude of limitations, despite bringing in millions of dollars in taxes every year.

Additionally, cannabis production typically involves a variety of cross-sector activities such as agriculture, manufacturing, retail, and even hospitality and events. These are all sectors that tend to be high value and have a greater impact on the economy. Rather than just estimating the amount of tax dollars cannabis would pump into the economy, this analysis looked at how the industry would impact the broader economy.

The researchers found that for every $10 spent at medical and recreational cannabis retail locations, an extra $18 would be injected into the local economy. This additional $18 would come from the hundreds of thousands of people who work in the cannabis industry through payments of housing and transportation, and other needs and wants.

As agricultural, manufacturing and retail ventures in the cannabis industry move to new regions, established companies such as Cannabis Strategic ventures Inc. (OTC: NUGS) are likely to continue expanding as well as they leverage their expertise and contribute to the growing economy.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures First-Ever Patent for DehydraTECH to Deliver Antiviral Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of its first-ever patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs. According to the update, Lexaria has received notification from the United States Patent and Trademark Office that patent 11,311,559 for “Compositions and Methods for Enhanced Delivery of Antiviral Agents” will be issued to the company on April 26, 2022. “This will be our 25th patent granted worldwide and another validation of the versatility of our DehydraTECH drug delivery technology,” said Chris Bunka, CEO of Lexaria. “This new patent adds to our existing suite of granted patents in the EU, the U.S., India, Japan and Australia, and continues to build value for Lexaria shareholders and clients.”

To view the full press release, visit https://cnw.fm/eGFRG

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is launching business-to-business sales of its rare cannabinoid cannabidivarin (“CBDV”). Through subsidiary BayMedica LLC, InMed will offer its product to wholesalers, suppliers and end-product manufacturers in the health and wellness sector. In addition, the company released a white paper focused on research into the therapeutic potential of CBDV. According to the announcement, CBDV is a nonintoxicating rare cannabinoid that is similar to CBD but offers important differences in activity. One of the most-studied rare cannabinoids, CBDV is currently the focus of several different clinical trials evaluating its use in the treatment of autism, Prader-Willi Syndrome and attention deficit hyperactivity disorder. “Ensuring a reliable, large volume source of highly pure, bioidentical CBDV is an important step forward in the health and wellness sector,” said BayMedica SVP and general manager Shane Johnson in the press release. “CBDV has been researched for its therapeutic potential in several disease areas such as autism spectrum disorder. Whether you are a researcher or product developer at a multinational consumer package goods company, the ability to access highly pure and consistent active ingredients, free from contaminants typically found in plant-sourced cannabinoids such as pesticides, heavy metals, or potentially even THC, is a fundamental requirement. BayMedica’s cannabinoid manufacturing technologies provides exactly that value and we are excited to continue to introduce to the market additional rare cannabinoids that have previously not been abundantly accessible, including adding THCV to our portfolio in the immediate future.”

To view the full press release, visit https://cnw.fm/vZjuN

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and is dedicated to delivering new treatment alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.  

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Boost Your Cannabis Business in Medellin as BizCann Expo Brings The Best Cannabis Services Together, Under One Roof!

Cannabis entrepreneurs, brand owners, and enthusiasts are all invited to the next edition of BizCann Expo in Medellín, Colombia this May 21-22nd 2022. Having hosted some phenomenal trade shows in numerous cities of the US, BizCann Expo is happy to announce their upcoming event in Medellin, helping local businesses expand and discover global avenues.

BizCann Expo is the perfect launchpad for unique business ideas, sharing innovations with industry peers and leaders, as well as discussing the various aspects and strategies for successful cannabis trading. Attendees can showcase their products and services with exhibitors, and those with in depth knowledge of the field can join the show as speakers!

This event aims to provide valuable information on the latest cannabis market trends, and offers a huge arena for joint venture collaborations. Participants can enjoy a variety of discussions, keynotes, and workshops. Plus, they’ll be able to find all resources that businesses need to grow and establish themselves in the cannabis industry. Here’s a few other things you can expect:

  • Learn about the latest cannabis legislations and attain CLE credits
  • Exhibit your talents and services to an enthusiastic audience, for a chance to be discovered by investors
  • Explore tactics for maintaining best practices and accounts in your cannabusiness
  • New businesses can learn directly from industry leaders at their selection of seminars, talks and panels
  • Discover an entire spectrum of resources necessary for kickstarting your cannabis business

To purchase tickets and learn more, please visit www.BizCannExpo.com.

BizCann Expo is an 18+ only event. 

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Southeastern Hemp & Medical Cannabis Convention, Helping to Shape The Future Of The Industry

Cannabis growers, traders, businesses, researchers, processors, testing laboratory personnel, facility management, and investors, are all invited to attend the SHMC (Southeastern Hemp & Medical Cannabis) Convention being held from the 12th to the 14th of May, 2022, at the Cobb Galleria Centre, Two Galleria Parkway, Atlanta, Georgia. The event, also to be streamed online for worldwide access, is organized by Organa Kannalytics LLC. 

The SHMC offers a robust platform for startups and industries to identify novel avenues of growth in this dynamic and budding industry. This convention attracts a vast profile of attendees from varied industry verticals seeking investment and business opportunities in the medical cannabis sector. 

Growing businesses can attain insights from distinguished speakers about the medical advancements, technological breakthroughs, legislative laws, and business prospects of the cannabis industry amidst the growing competition in the Southeastern U.S. region. This forum is all set to witness some of the strongest cannabis players looking to redefine the industry.

The emerging hemp and medical cannabis market offers a spectrum of possibilities waiting to be explored. Entrepreneurs, medical practitioners, cultivators, and traders can leverage the mammoth networking scope of this impactful 2-day event to tap the huge cannabis market at their disposal. 

LUX LEAF Diagnostics, the title sponsor of SHMCC, is a leading testing laboratory dedicated to serving the US market. Sponsors and vendors can set up their individual booths or showcase their products and services. Earlybird discounts are available.

Speakers include:

  • Tavarres King – King is a veteran player of the National Football League, and CEO of Rowdy Wellness, an Atlanta-based CBD company engaged in the research, education, and development of quality health and wellness products.
  • Dallas Austin – Austin is a legendary songwriter, now owner of Rowdy Wellness, and an active cannabis advocate down south

Participants will have access to panel discussions, workshops, speaker sessions on important industry topics, and breaks for building important networking ties. The agenda of the SMHCC is focused on building strong networking contacts for young businesses, as well as educating and creating awareness about the advancement, business scope, and the regulatory local, state, and national legislation relevant to the medical cannabis industry. 

The team at SHMCC is committed to the safety of the attendees at the physical event and will ensure all health and safety protocols are followed. 

To learn more, please visit https://www.organakannalytics.com/.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — American Marijuana Consumers See Investment Opportunities in European Cannabis Sector

According to a survey conducted by Bloomwell Group, a medical cannabis holding company, consumers of marijuana in the United States believe that the widely anticipated legalization of recreational cannabis in Germany will create great opportunities for investment, travel and trade. The survey found that 80% of American cannabis consumers were convinced that great investment opportunities exist in marijuana companies. Six in ten individuals surveyed also revealed that they would invest in European-based marijuana stocks.

The new coalition government in Germany made up of the SDP party, the Greens and the FDP party announced last year that adult-use marijuana would be legalized and sold in licensed outlets. Although no definitive schedule for this legalization was given, the news has created massive excitement because of its ramifications for the cannabis industry in Germany (where medical marijuana is already legal) and the broader European Union block.

It is expected that once Germany opens its cannabis market fully, there will be a domino effect of legalizations in other countries in mainland Europe. Additionally, Germany is likely to be the largest marijuana market in the world given that its population is bigger than that of California or Canada, the two jurisdictions that currently dominate the legal cannabis industry.

The Bloomwell Group survey polled 845 marijuana users in the U.S. in order to determine their views about the upcoming marijuana legalization in Germany. A huge majority (87%) were of the view that cannabis prohibition should be ended globally, while 52% acknowledged that Germany will become the largest cannabis market once legalization takes effect. An estimated 65% of the survey respondents expressed a desire to visit a German city in order to experience what its marijuana industry was like.

The respondents also revealed their awareness that massive investment opportunities would open up when legalization is implemented. This expectation is supported by an analysis conducted by BDSA showing that the German cannabis industry has the potential to generate at least $3 billion annually three years from its opening. Other analysts forecast a market size of at least $10 billion annually if the supply challenges that plagued the launch of the medical marijuana market are avoided.

The U.S. cannabis industry has a huge opportunity to plug those supply gaps, at least in the beginning, if the needed regulatory reforms can be passed at the federal level. For example, the passing of the MORE Act can allow American companies to transact with the German marijuana sector without impediment.

If those reforms don’t happen soon enough, the United States risks being a bystander as cannabis takes off in one country after another on the European continent and globally. Such an eventuality would rob entities such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) of a great opportunity to expand into Europe and make their mark on that huge market.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — DEA Admits Less Mexican Marijuana is Getting into US Because of State Legalization

In a new report presented to Congress, the U.S. Drug Enforcement Administration reveals that as more cannabis is produced domestically, smuggling from Mexico is being undermined.

These comments are part of the federal agency’s Fiscal Year Performance estimates for 2023. In that report, the DEA talks about what it is doing to boost marijuana research, including ending the monopoly of Mississippi University in producing cannabis for federally sanctioned research projects.

While the DEA wasn’t forthright in admitting that most U.S. residents are now opting for legally produced marijuana within the country, it did indicate that domestically produced cannabis had outmuscled that originating in Mexico.

Data exists to support the belief that local marijuana laws have had a big role to play in taming the flow of cannabis from Mexico. For instance, a 2018 study undertaken by the Cato Institute concluded that state-level marijuana policy reforms had significantly undercut cannabis smuggling.

The budget document released by the DEA makes reference to the increase in the domestically produced marijuana from a new source — companies that have the DEA’s approval to manufacture marijuana for research purposes. The agency reveals that approved manufacturers have increased from one to four, and an additional two are due to get the nod by this year’s end.

The drugs agency also details how it plans to ramp up the production of cannabis for research purposes. However, the agency’s document is quiet about the notable increase in the quantity of various psychedelic compounds such as MDMA and psilocybin, as interest grows in studying these substances as treatments for mental health disorders and other clinical indications.

In addition to the document presented in Congress, the DEA recently clarified that under existing laws, the popular delta-8 THC wasn’t categorized as a controlled substance. The DEA mentioned that only those products having more than 0.3% delta-9 THC fell under the regulatory framework of the DEA since existing law doesn’t ban isomers of THC. Similarly, the DEA indicated that marijuana seeds aren’t illegal nor do they fall into the  controlled substances category, in spite of how much THC may be found in the buds harvested after those seeds are cultivated. This is because federal law legalized hemp.

Another noteworthy trend is the increasing declines in federal prosecutions on marijuana-related charges. In 2021, less than 1,000 cases of cannabis trafficking were prosecuted. This is according to the United States Sentencing Commission (USSC).  Such statistics indicate that marijuana offenses are gradually slipping down on the priority list for law enforcement agencies at the federal level. In 2020, the same federal body recorded 1,118 marijuana cases.

The roundabout admission by the DEA that state-legal marijuana policies and companies such as American Cannabis Partners are helping to stem the tide of marijuana smuggling from across the border in Mexico proves yet again that ending cannabis prohibition has far-reaching beneficial effects for the economy and communities.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Pursuing Diversification, Increased Share in Booming Colorado Market

Hero Technologies (OTC: HENC) anticipates expanding into the booming Colorado cannabis market via cultivation and dispensary operations through its wholly owned subsidiary, Mile High Green LLC. “Cannabis sales in the state broke another record last year, topping $2.22 billion in products sold, according to the Colorado Department of Revenue (https://cnw.fm/SFXzA). This figure ‘eclipses’ 2020 sales reaching upwards of $2.1 billion, which set a previous record,” a recent article reads. “Hero Technologies announced the formation of Mile High Green in March of last year, stating that the purpose of the subsidiary was to seek cannabis, land purchase and strategic acquisition opportunities in the state of Colorado. ‘By establishing another subsidiary to target cannabis property acquisitions and cannabis licenses, we continue to aggressively pursue our diversification and integration strategy,’ said Hero Technologies CEO Gina Serkasevich. ‘Colorado is an obvious market for us to target for expansion. It was exciting to see the state’s cannabis sales soar to $2.2 billion in 2020, truly an all-time high. We will work hard to gain market share in this important territory and participate in its healthy growth.’”

To view the full article, visit https://cnw.fm/oQQAk

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.